A randomised crossover trial comparing photobiomodulation therapy with other recovery strategies in CrossFit athletes.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 42172262.
- Also identified by DOI 10.1371/journal.pone.0349880 and PMC identifier 13196929.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study compared the effects of different therapeutic modalities on recovery following the workout of the day (WOD) in CrossFit athletes, focusing on reducing muscle damage and improving functional performance. In a randomised, controlled, crossover design, twelve CrossFit athletes underwent four post-WOD recovery interventions across four weeks: passive recovery (PR), intermittent pneumatic compression (IPC), extracorporeal shock wave therapy (ESWT), and photobiomodulation therapy combined with a static magnetic field (PBMT-sMF). Assessments were conducted at baseline, and at 1, 24, and 48 hours post-WOD. The primary outcome was vertical jump performance (countermovement jump [CMJ] height) at 1-hour post-WOD; secondary outcomes included lactate dehydrogenase (LDH) levels, superoxide dismutase (SOD) and catalase (CAT) activity, thiobarbituric acid reactive substances (TBARS), carbonylated proteins, perceived exertion, and intervention satisfaction. There was no significant difference between interventions in CMJ height at 1-hour post-WOD. In contrast, PBMT-sMF outperformed the other interventions in the secondary outcomes. PBMT-sMF significantly improved CMJ height at 24 and 48 hours compared with PR (p < 0.05) and led to greater reductions in LDH at both time points (p < 0.05 and p < 0.001, respectively). PBMT-sMF also produced lower TBARS and carbonylated protein levels, with higher CAT and SOD activities at 24 and 48 hours (p < 0.05 and p < 0.0001, respectively). CAT and SOD activities were also significantly elevated at 1 hour post-WOD compared with PR (p < 0.05). PBMT-sMF may be an effective recovery strategy for CrossFit athletes, with its benefits possibly related to the modulation of oxidative stress as an underlying mechanism. Trial registration number: NCT06628609.
Medical subject headings
- Athletes
- Low-Level Light Therapy